Thermo Fisher Scientific Inc (TMO)

Industry Diagnostics & Research


This stock can be held in an Investment ISA and an Investment Account
Sell

$559.57

Buy

$570.05

arrow-down$-7.60 (-1.33%)

Prices updated at 17 Dec 2025, 21:10 EST
| Prices minimum 15 mins delay
|
Prices in USD

Thermo Fisher Scientific Inc is a healthcare company. It offers analytical instruments, laboratory equipment, software, services, consumables, reagents and chemicals.

Income statement

20232024
42,857m42,879m
17,100m17,702m
7,318m7,717m
17.0818.00
5,995m6,335m
11,079m11,535m
Sales, General and administrative8,445m8,595m
Interest expenses1,375m1,390m
Provision for income taxes284m657m
Operating expenses9,782m9,985m
Income before taxes6,298m7,037m
Net income available to common shareholders5,995m6,335m
15.5216.58
Net interest income-496m-312m
Advertising and promotion--
Net investment income, net--
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)15.4516.53
Free cash flow per share16.838620.2342
Book value/share117.2334128.6641
Debt equity ratio0.6699050.586085

Balance sheet

20232024
Current assets24,589m22,137m
Current liabilities14,012m13,332m
Total capital78,043m78,646m
Total debt34,917m31,275m
Total equity46,735m49,585m
Total non current liabilities--
Loans31,308m29,061m
Total assets98,726m97,321m
Total liabilities--
Cash and cash equivalents8,077m4,009m
Common stock387m381m

Cash flow

20232024
Cash at beginning of period8,537m8,097m
Cash dividends paid-523m-583m
6,927m7,267m
Investments (gains) losses-5,142m-5,841m
8,097m4,040m
Net income--
8,406m8,667m
-1,479m-1,400m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.